Novonesis (Novozymes) A/S - Asset Resilience Ratio
Novonesis (Novozymes) A/S (NSIS-B) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Novonesis (Novozymes) A/S (NSIS-B) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Novonesis (Novozymes) A/S's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Novonesis (Novozymes) A/S.
Liquid Assets Composition Over Time
This chart breaks down Novonesis (Novozymes) A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Novonesis (Novozymes) A/S long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr2.20 Million | 0.01% |
| Total Liquid Assets | Dkr2.20 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Novonesis (Novozymes) A/S maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Novonesis (Novozymes) A/S Industry Peers by Asset Resilience Ratio
Compare Novonesis (Novozymes) A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang Longsheng Group Co Ltd
SHG:600352 |
Specialty Chemicals | 0.80% |
|
Ningbo Shanshan Co Ltd
SHG:600884 |
Specialty Chemicals | 0.00% |
|
GCH Technology Co. Ltd. A
SHG:688625 |
Specialty Chemicals | 21.54% |
|
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238 |
Specialty Chemicals | 40.33% |
|
Chongqing Zaisheng Tech Corp
SHG:603601 |
Specialty Chemicals | 13.69% |
|
Anhui Guofeng Plastic Industry Co Ltd
SHE:000859 |
Specialty Chemicals | 3.12% |
|
Daxin Materials Corp
TW:5234 |
Specialty Chemicals | 28.38% |
|
Sino-High (China) Co. Ltd.
SHE:301076 |
Specialty Chemicals | 40.33% |
Annual Asset Resilience Ratio for Novonesis (Novozymes) A/S (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Novonesis (Novozymes) A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.12% | Dkr20.30 Million ≈ $3.18 Million |
Dkr16.35 Billion ≈ $2.56 Billion |
+0.10pp |
| 2024-12-31 | 0.03% | Dkr4.00 Million ≈ $625.83K |
Dkr15.20 Billion ≈ $2.38 Billion |
-0.11pp |
| 2023-12-31 | 0.14% | Dkr40.00 Million ≈ $6.26 Million |
Dkr28.39 Billion ≈ $4.44 Billion |
-0.14pp |
| 2022-12-31 | 0.29% | Dkr80.00 Million ≈ $12.52 Million |
Dkr27.98 Billion ≈ $4.38 Billion |
-0.02pp |
| 2021-12-31 | 0.30% | Dkr75.00 Million ≈ $11.73 Million |
Dkr24.77 Billion ≈ $3.87 Billion |
-0.28pp |
| 2020-12-31 | 0.58% | Dkr119.00 Million ≈ $18.62 Million |
Dkr20.51 Billion ≈ $3.21 Billion |
+0.51pp |
| 2019-12-31 | 0.07% | Dkr15.00 Million ≈ $2.35 Million |
Dkr20.44 Billion ≈ $3.20 Billion |
+0.00pp |
| 2018-12-31 | 0.07% | Dkr14.00 Million ≈ $2.19 Million |
Dkr19.70 Billion ≈ $3.08 Billion |
-0.02pp |
| 2017-12-31 | 0.09% | Dkr16.00 Million ≈ $2.50 Million |
Dkr18.37 Billion ≈ $2.87 Billion |
+0.07pp |
| 2016-12-31 | 0.02% | Dkr4.00 Million ≈ $625.83K |
Dkr18.66 Billion ≈ $2.92 Billion |
-0.09pp |
| 2015-12-31 | 0.11% | Dkr20.00 Million ≈ $3.13 Million |
Dkr17.79 Billion ≈ $2.78 Billion |
+0.02pp |
| 2014-12-31 | 0.09% | Dkr17.00 Million ≈ $2.66 Million |
Dkr18.43 Billion ≈ $2.88 Billion |
-0.43pp |
| 2013-12-31 | 0.53% | Dkr87.00 Million ≈ $13.61 Million |
Dkr16.51 Billion ≈ $2.58 Billion |
+0.23pp |
| 2012-12-31 | 0.30% | Dkr45.00 Million ≈ $7.04 Million |
Dkr15.11 Billion ≈ $2.36 Billion |
-0.05pp |
| 2011-12-31 | 0.35% | Dkr48.00 Million ≈ $7.51 Million |
Dkr13.84 Billion ≈ $2.17 Billion |
-1.07pp |
| 2010-12-31 | 1.41% | Dkr178.00 Million ≈ $27.85 Million |
Dkr12.59 Billion ≈ $1.97 Billion |
-0.81pp |
| 2006-12-31 | 2.22% | Dkr177.00 Million ≈ $27.69 Million |
Dkr7.96 Billion ≈ $1.25 Billion |
+0.16pp |
| 2005-12-31 | 2.07% | Dkr151.00 Million ≈ $23.63 Million |
Dkr7.31 Billion ≈ $1.14 Billion |
+0.76pp |
| 2004-12-31 | 1.30% | Dkr93.00 Million ≈ $14.55 Million |
Dkr7.13 Billion ≈ $1.12 Billion |
-0.20pp |
| 2003-12-31 | 1.51% | Dkr115.00 Million ≈ $17.99 Million |
Dkr7.63 Billion ≈ $1.19 Billion |
-0.48pp |
| 2002-12-31 | 1.99% | Dkr166.00 Million ≈ $25.97 Million |
Dkr8.35 Billion ≈ $1.31 Billion |
-- |
About Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The c… Read more